Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 380.3 M412.6 M451.6 M433.7 M427 M — Research & development ————— — Operating income 145 M-23.3 M122.7 M123.1 M132.7 M — Non-Operating Income, Total -47.6 M-45.8 M-51.5 M-49.8 M-47.6 M — Interest expense, net of interest capitalized 29.2 M29 M29.2 M111.8 M— — Non-Operating Income, excl. Interest Expenses -47.6 M-45.7 M-51.4 M-50.1 M-47.7 M — Unusual income/expense 0-100 K-100 K300 K100 K — Pretax income 97.4 M-69.1 M71.2 M73.3 M85.1 M — Equity in earnings ————— — Taxes 26.8 M-23.5 M24.4 M-81.8 M24.3 M — Non-controlling/minority interest ————— — After tax other income/expense ————— — Net income before discontinued operations 70.6 M-45.6 M46.8 M46.9 M60.8 M — Discontinued operations ————— — Net income 70.6 M-45.6 M46.8 M46.9 M60.8 M — Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders 70.6 M-45.6 M46.8 M46.9 M— — Basic earnings per share (Basic EPS) 2.09-1.341.371.371.81 — Diluted earnings per share (Diluted EPS) 2.04-1.341.331.391.79 — Average basic shares outstanding 33.9 M34.1 M34.2 M34 M33.6 M — Diluted shares outstanding 34.6 M34.1 M35.1 M34.7 M34 M — EBITDA 146.6 M323.1 M124.4 M-222.8 M— — EBIT 147.8 M321.5 M122.7 M-224.5 M— — Cost of revenue 3.08 B3.06 B3.36 B3.27 B— — Other cost of goods sold ————— — Depreciation & amortization (cash flow) 1.6 M1.6 M1.7 M1.7 M— —